Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
OxyHeal International, commonly referred to as OxyHeal Health Group, is a long-standing hyperbaric medicine company focused on commercial hyperbaric oxygen therapy solutions for hospitals and wound-care settings. The company historically combined clinical service operations, medical staffing, education, research support, and the design and manufacture of monoplace and multiplace hyperbaric chamber systems. In 2016, CutisCare and Bison Capital acquired OxyHeal's U.S. clinical operations, while the device-manufacturing business later continued under the name Hyperbaric Modular Systems. OxyHeal's business has centered on turnkey hyperbaric medicine programs, wound-healing center support, and custom hyperbaric chamber systems for healthcare, research, diving, and tunneling applications.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on OxyHeal International.